Ignacio Pedrós

982 total citations
15 papers, 779 citations indexed

About

Ignacio Pedrós is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Ignacio Pedrós has authored 15 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Ignacio Pedrós's work include Alzheimer's disease research and treatments (10 papers), Nuclear Receptors and Signaling (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Ignacio Pedrós is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Nuclear Receptors and Signaling (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Ignacio Pedrós collaborates with scholars based in Spain, Mexico and Ecuador. Ignacio Pedrós's co-authors include Jaume Folch, Antoni Camins, Dmitry S. Petrov, Carlos Beas‐Zárate, Mercè Pallàs, Miren Ettcheto, Carme Auladell, Sònia Abad, Francesc X. Sureda and Miguel Marín and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Ignacio Pedrós

15 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Pedrós Spain 13 463 236 164 132 129 15 779
Dmitry S. Petrov Spain 14 573 1.2× 291 1.2× 203 1.2× 220 1.7× 174 1.3× 28 975
Oriol Busquets Spain 17 389 0.8× 284 1.2× 137 0.8× 165 1.3× 165 1.3× 31 888
Daiane F. Engel Brazil 19 272 0.6× 259 1.1× 156 1.0× 119 0.9× 148 1.1× 31 970
Guodong Li China 21 270 0.6× 295 1.3× 119 0.7× 79 0.6× 122 0.9× 41 913
Masato Maesako United States 18 577 1.2× 347 1.5× 145 0.9× 95 0.7× 200 1.6× 39 910
Afzal Misrani China 13 286 0.6× 289 1.2× 167 1.0× 95 0.7× 124 1.0× 22 798
Loukia Katsouri United Kingdom 13 421 0.9× 355 1.5× 191 1.2× 78 0.6× 170 1.3× 20 822
David Porquet Spain 13 456 1.0× 324 1.4× 182 1.1× 86 0.7× 96 0.7× 19 1.0k
Leonardo P. Navarrete Chile 7 516 1.1× 347 1.5× 340 2.1× 172 1.3× 146 1.1× 8 1.1k
Anna Mietelska‐Porowska Poland 12 525 1.1× 334 1.4× 206 1.3× 100 0.8× 194 1.5× 16 1.0k

Countries citing papers authored by Ignacio Pedrós

Since Specialization
Citations

This map shows the geographic impact of Ignacio Pedrós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Pedrós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Pedrós more than expected).

Fields of papers citing papers by Ignacio Pedrós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Pedrós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Pedrós. The network helps show where Ignacio Pedrós may publish in the future.

Co-authorship network of co-authors of Ignacio Pedrós

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Pedrós. A scholar is included among the top collaborators of Ignacio Pedrós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Pedrós. Ignacio Pedrós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ettcheto, Miren, Sònia Abad, Dmitry S. Petrov, et al.. (2017). Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease. Molecular Neurobiology. 55(6). 4885–4895. 23 indexed citations
2.
Folch, Jaume, Miren Ettcheto, Dmitry S. Petrov, et al.. (2017). Review of the advances in treatment for Alzheimer disease: strategies for combating β-amyloid protein. SHILAP Revista de lepidopterología. 33(1). 47–58. 77 indexed citations
3.
Ettcheto, Miren, Dmitry S. Petrov, Ignacio Pedrós, et al.. (2016). Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer’s Disease Stage in APP/PS1 Mice. Journal of Alzheimer s Disease. 54(1). 233–251. 47 indexed citations
4.
Petrov, Dmitry S., Ignacio Pedrós, Gonzalo Artiach, et al.. (2015). High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(9). 1687–1699. 133 indexed citations
5.
Petrov, Dmitry S., Ignacio Pedrós, Miren Ettcheto, et al.. (2015). Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer’s Disease. Molecular Neurobiology. 53(9). 6183–6193. 24 indexed citations
6.
Folch, Jaume, Dmitry S. Petrov, Miren Ettcheto, et al.. (2015). Masitinib for the treatment of mild to moderate Alzheimer’s disease. Expert Review of Neurotherapeutics. 15(6). 587–596. 58 indexed citations
7.
Folch, Jaume, Miren Ettcheto, Dmitry S. Petrov, et al.. (2015). Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide. Neurología. 33(1). 47–58. 81 indexed citations
8.
Folch, Jaume, Ignacio Pedrós, Dmitry S. Petrov, et al.. (2015). The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. Life Sciences. 140. 19–28. 34 indexed citations
9.
Ettcheto, Miren, Dmitry S. Petrov, Ignacio Pedrós, et al.. (2015). Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice. Experimental Gerontology. 65. 69–78. 21 indexed citations
10.
Pedrós, Ignacio, Dmitry S. Petrov, Francesc X. Sureda, et al.. (2014). Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1556–1566. 170 indexed citations
11.
Pedrós, Ignacio, Dmitry S. Petrov, Gonzalo Artiach, et al.. (2014). Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease. The journal of nutrition health & aging. 19(4). 403–412. 18 indexed citations
12.
Petrov, Dmitry S., Ignacio Pedrós, Mercè Pallàs, et al.. (2014). Mavoglurant as a treatment for Parkinson’s disease. Expert Opinion on Investigational Drugs. 23(8). 1165–1179. 30 indexed citations
13.
Folch, Jaume, et al.. (2013). Metabolic Basis of Sporadic Alzeimer’s Disease. Role of Hormones Related to Energy Metabolism. Current Pharmaceutical Design. 19(38). 6739–6748. 12 indexed citations
14.
Folch, Jaume, Ignacio Pedrós, Francesc X. Sureda, et al.. (2012). Neuroprotective and anti-ageing role of leptin. Journal of Molecular Endocrinology. 49(3). R149–R156. 50 indexed citations
15.
Navarro, Justo García, et al.. (2004). Construcción, paisaje y arte: los cubos de la memoria. Informes de la Construcción. 55(489). 5–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dmitry S. Petrov Breakdown of academic impact, for papers by Oriol Busquets Breakdown of academic impact, for papers by Daiane F. Engel Breakdown of academic impact, for papers by Guodong Li Breakdown of academic impact, for papers by Masato Maesako Breakdown of academic impact, for papers by Afzal Misrani Breakdown of academic impact, for papers by Loukia Katsouri Breakdown of academic impact, for papers by David Porquet Breakdown of academic impact, for papers by Leonardo P. Navarrete Breakdown of academic impact, for papers by Anna Mietelska‐Porowska
Rankless by CCL
2026